Curaleaf Holdings Saturday Close: Rescheduling Hearing Conclusion and Multi-State Scale Anchor the July Catalyst Case
TL;DR: Curaleaf Holdings (OTCQX: CURLF), the largest US multi-state operator by store count, closes Saturday at a pivotal moment as DEA rescheduling hearings approach their final phase. The combination of a potential favorable ruling and ongoing 280E tax normalization creates a compounding earnings catalyst that disproportionately favors large-footprint operators. As investors position ahead of the […]
Canopy Growth Saturday Afternoon LP Review: Canopy USA Structure and International Medical Revenue Define the Post-Restructuring Thesis
TL;DR: Canopy Growth (Nasdaq: CGC) has spent the past 18 months restructuring its balance sheet and concentrating on two growth levers — international medical cannabis exports and the Canopy USA holding structure designed to capture U.S. MSO exposure the moment federal law permits. Saturday afternoon trading sees CGC consolidating in a range that reflects the […]
Innovative Industrial Properties Saturday Brief: Cannabis REIT Positioned as Rescheduling Unlocks Institutional Capital
TL;DR: Innovative Industrial Properties (NYSE: IIPR) — the cannabis sector’s only publicly traded REIT — is positioned to benefit as federal rescheduling progress begins normalizing the institutional risk calculus for cannabis-adjacent real estate. With MSOS sector equities at 2026 highs and operator balance sheets improving under reduced 280E burdens, demand for sale-leaseback financing is rising, […]
Cannabis Market Week-Ahead June 29: MSOS Locks 2026 Highs as Rescheduling Hearings Near Conclusion
TL;DR: Cannabis equities finished Friday, June 26 near session highs as the MSOS ETF extended its best weekly performance of 2026, buoyed by a second constructive day of DEA administrative rescheduling hearings. With the holiday-shortened week of June 29 ahead, investors will focus on rescheduling timeline developments, imminent Q2 earnings prints from top MSOs, and […]
Green Thumb Industries Q2 2026 Earnings Preview: Free Cash Flow and 280E Savings in Focus
TL;DR: Green Thumb Industries (GTBIF) is set to report Q2 2026 results in late July, and analysts are watching three key metrics: free cash flow generation, the early financial impact of 280E relief from April’s medical rescheduling, and same-store sales trends across its 98 retail locations. With MSOS at 2026 highs and rescheduling hearings underway, […]
280E in Two Acts: How April Medical Rescheduling Changed MSO Taxes and What Adult-Use Hearings Would Complete
TL;DR: The April 23 rescheduling of medical cannabis to Schedule III delivered the first real relief from Section 280E in the federal tax code’s three-decade grip on the cannabis industry. But for the largest multi-state operators — whose revenues are overwhelmingly adult-use — the more consequential change awaits the outcome of the ongoing DOJ adult-use […]
MSOS Sector Positions for a Pivotal Friday as DOJ Rescheduling Hearings Begin — Outlook for June 26
TL;DR: Thursday, June 25 delivered a trifecta of structural catalysts for the cannabis sector — DOJ rescheduling hearings formally opened, Tilray posted record international revenue, and Curaleaf cleared a major uplisting hurdle. With the MSOS sector holding near 2026 highs heading into Friday’s session, investors are now watching for hearing testimony and follow-through volume to […]
DOJ Begins Adult-Use Cannabis Rescheduling Hearings — Full 280E Relief Now on the Table
TL;DR: The U.S. Department of Justice has opened formal hearings in late June 2026 to evaluate rescheduling adult-use cannabis from Schedule I, following the landmark April 23 move of medical cannabis to Schedule III. A successful outcome would eliminate 280E taxation entirely for multi-state operators (MSOs), potentially unlocking hundreds of millions in annual cash flow […]
Institutional Capital Flows Into Cannabis ETFs Accelerate
By Sheeba M. | June 05, 2026 Institutional Capital Flows Into Cannabis ETFs Accelerate TL;DR: Major institutional investors are increasing exposure to cannabis equities via diversified ETFs, signaling confidence in near-term federal legalization catalysts and margin expansion as MSOs scale operations. The past quarter has witnessed a notable uptick in capital allocation toward cannabis sector […]